| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Injuries | 16 | 2015 | 715 | 2.980 |
Why?
|
| Brain Injuries, Traumatic | 6 | 2022 | 300 | 1.810 |
Why?
|
| Decompressive Craniectomy | 4 | 2021 | 15 | 1.640 |
Why?
|
| Recovery of Function | 5 | 2017 | 461 | 1.400 |
Why?
|
| Ganglia, Spinal | 6 | 2016 | 69 | 1.390 |
Why?
|
| Brain Neoplasms | 8 | 2023 | 1410 | 1.300 |
Why?
|
| Glioblastoma | 5 | 2020 | 374 | 1.200 |
Why?
|
| Stress, Psychological | 4 | 2022 | 577 | 1.160 |
Why?
|
| Neurodegenerative Diseases | 3 | 2023 | 281 | 1.090 |
Why?
|
| Blood-Brain Barrier | 6 | 2022 | 156 | 1.070 |
Why?
|
| Mental Disorders | 4 | 2020 | 893 | 1.030 |
Why?
|
| Neuronal Plasticity | 3 | 2018 | 277 | 1.020 |
Why?
|
| Spinal Cord Injuries | 4 | 2019 | 261 | 1.010 |
Why?
|
| Hippocampus | 7 | 2022 | 818 | 0.960 |
Why?
|
| Sciatic Neuropathy | 2 | 2016 | 8 | 0.940 |
Why?
|
| Brain | 9 | 2022 | 3198 | 0.880 |
Why?
|
| Wakefulness | 2 | 2023 | 105 | 0.870 |
Why?
|
| Spinal Cord | 4 | 2021 | 276 | 0.860 |
Why?
|
| Nerve Regeneration | 5 | 2014 | 85 | 0.840 |
Why?
|
| Neurons | 7 | 2016 | 2013 | 0.830 |
Why?
|
| Ketorolac | 1 | 2023 | 11 | 0.810 |
Why?
|
| Ultrasonics | 1 | 2023 | 37 | 0.800 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 1 | 2022 | 11 | 0.790 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2022 | 43 | 0.780 |
Why?
|
| Disease Models, Animal | 16 | 2022 | 4688 | 0.750 |
Why?
|
| Astrocytes | 2 | 2023 | 270 | 0.730 |
Why?
|
| Neurosurgery | 2 | 2020 | 82 | 0.720 |
Why?
|
| Neuronavigation | 1 | 2021 | 10 | 0.710 |
Why?
|
| Cranial Sinuses | 1 | 2021 | 12 | 0.700 |
Why?
|
| Occupational Health | 1 | 2020 | 47 | 0.650 |
Why?
|
| Hydrocephalus | 1 | 2023 | 276 | 0.650 |
Why?
|
| Tissue Engineering | 4 | 2009 | 168 | 0.640 |
Why?
|
| Opioid-Related Disorders | 1 | 2023 | 286 | 0.630 |
Why?
|
| Humans | 77 | 2023 | 131930 | 0.630 |
Why?
|
| Neurosurgical Procedures | 4 | 2020 | 317 | 0.620 |
Why?
|
| DNA Modification Methylases | 1 | 2019 | 50 | 0.610 |
Why?
|
| DNA Repair Enzymes | 1 | 2019 | 43 | 0.610 |
Why?
|
| Ultrasonography, Interventional | 1 | 2021 | 208 | 0.600 |
Why?
|
| Cervical Cord | 1 | 2019 | 10 | 0.600 |
Why?
|
| Occupational Exposure | 1 | 2020 | 131 | 0.600 |
Why?
|
| Neck Injuries | 1 | 2019 | 24 | 0.600 |
Why?
|
| Hemangioblastoma | 1 | 2018 | 12 | 0.590 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 865 | 0.590 |
Why?
|
| Sepsis | 1 | 2023 | 515 | 0.580 |
Why?
|
| Animals | 35 | 2023 | 34908 | 0.570 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 2017 | 18 | 0.550 |
Why?
|
| Ectopic Gene Expression | 1 | 2017 | 3 | 0.540 |
Why?
|
| Rats | 12 | 2022 | 3606 | 0.530 |
Why?
|
| Intervertebral Disc Degeneration | 1 | 2017 | 17 | 0.530 |
Why?
|
| Intervertebral Disc | 1 | 2017 | 14 | 0.530 |
Why?
|
| Solute Carrier Family 12, Member 2 | 1 | 2016 | 7 | 0.520 |
Why?
|
| Schwann Cells | 2 | 2014 | 66 | 0.510 |
Why?
|
| Epilepsy, Post-Traumatic | 1 | 2016 | 12 | 0.510 |
Why?
|
| Peripheral Nervous System Diseases | 2 | 2016 | 137 | 0.510 |
Why?
|
| Emotions | 2 | 2016 | 367 | 0.500 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2017 | 376 | 0.500 |
Why?
|
| Myelin Proteins | 2 | 2014 | 79 | 0.490 |
Why?
|
| Male | 41 | 2021 | 64846 | 0.480 |
Why?
|
| Norepinephrine | 1 | 2016 | 166 | 0.480 |
Why?
|
| Vascular Neoplasms | 1 | 2016 | 33 | 0.480 |
Why?
|
| Neural Stem Cells | 2 | 2014 | 149 | 0.470 |
Why?
|
| Central Nervous System Diseases | 1 | 2016 | 109 | 0.460 |
Why?
|
| Failed Back Surgery Syndrome | 1 | 2014 | 3 | 0.460 |
Why?
|
| Action Potentials | 2 | 2016 | 495 | 0.460 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 378 | 0.450 |
Why?
|
| Cerebellum | 1 | 2018 | 463 | 0.450 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 389 | 0.450 |
Why?
|
| Lumbar Vertebrae | 3 | 2023 | 113 | 0.440 |
Why?
|
| Peripheral Nervous System Neoplasms | 2 | 2004 | 12 | 0.440 |
Why?
|
| Brain Injury, Chronic | 1 | 2014 | 18 | 0.440 |
Why?
|
| Cerebellar Neoplasms | 1 | 2018 | 461 | 0.430 |
Why?
|
| Young Adult | 13 | 2021 | 9929 | 0.430 |
Why?
|
| Middle Aged | 24 | 2021 | 28893 | 0.430 |
Why?
|
| Up-Regulation | 2 | 2016 | 880 | 0.430 |
Why?
|
| Neuralgia | 1 | 2014 | 50 | 0.430 |
Why?
|
| S100 Proteins | 1 | 2014 | 47 | 0.430 |
Why?
|
| Receptors, Cell Surface | 2 | 2014 | 451 | 0.430 |
Why?
|
| Neuroglia | 1 | 2016 | 214 | 0.430 |
Why?
|
| Meningioma | 1 | 2016 | 141 | 0.430 |
Why?
|
| Craniotomy | 3 | 2023 | 107 | 0.420 |
Why?
|
| Neurilemmoma | 2 | 2004 | 47 | 0.420 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2016 | 152 | 0.420 |
Why?
|
| Neurologic Examination | 2 | 2014 | 202 | 0.420 |
Why?
|
| Meningeal Neoplasms | 1 | 2016 | 216 | 0.410 |
Why?
|
| Adult | 23 | 2023 | 31506 | 0.410 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2014 | 140 | 0.410 |
Why?
|
| Athletic Injuries | 1 | 2014 | 66 | 0.410 |
Why?
|
| Warfare | 1 | 2012 | 34 | 0.390 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2018 | 1224 | 0.380 |
Why?
|
| Pandemics | 1 | 2020 | 1185 | 0.380 |
Why?
|
| Blast Injuries | 1 | 2012 | 61 | 0.380 |
Why?
|
| Mice, Inbred C57BL | 10 | 2022 | 4757 | 0.380 |
Why?
|
| Memory Disorders | 1 | 2014 | 209 | 0.380 |
Why?
|
| Cell Transplantation | 1 | 2012 | 42 | 0.370 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2012 | 40 | 0.360 |
Why?
|
| Cervical Vertebrae | 3 | 2017 | 117 | 0.360 |
Why?
|
| Sleep Wake Disorders | 1 | 2014 | 197 | 0.360 |
Why?
|
| Aged | 16 | 2020 | 21394 | 0.360 |
Why?
|
| Imipramine | 1 | 2011 | 18 | 0.360 |
Why?
|
| Aging | 2 | 2017 | 1252 | 0.330 |
Why?
|
| Cognition Disorders | 2 | 2012 | 571 | 0.330 |
Why?
|
| Cell Proliferation | 4 | 2021 | 2509 | 0.330 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 685 | 0.320 |
Why?
|
| GPI-Linked Proteins | 3 | 2023 | 107 | 0.320 |
Why?
|
| Motor Activity | 1 | 2013 | 521 | 0.320 |
Why?
|
| Female | 30 | 2021 | 70607 | 0.310 |
Why?
|
| Axons | 4 | 2021 | 394 | 0.310 |
Why?
|
| Mice | 15 | 2023 | 18534 | 0.310 |
Why?
|
| Nerve Sheath Neoplasms | 3 | 2009 | 23 | 0.310 |
Why?
|
| Neoplastic Stem Cells | 3 | 2021 | 348 | 0.300 |
Why?
|
| Peripheral Nerves | 1 | 2009 | 88 | 0.300 |
Why?
|
| Neurogenesis | 1 | 2011 | 221 | 0.300 |
Why?
|
| Critical Care | 2 | 2014 | 686 | 0.300 |
Why?
|
| Adolescent | 12 | 2023 | 20524 | 0.300 |
Why?
|
| Mass Screening | 1 | 2014 | 830 | 0.290 |
Why?
|
| Brachial Plexus | 2 | 2009 | 20 | 0.290 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2008 | 39 | 0.280 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 1303 | 0.280 |
Why?
|
| Retrospective Studies | 11 | 2023 | 17345 | 0.270 |
Why?
|
| Cognition | 1 | 2013 | 810 | 0.270 |
Why?
|
| Anxiety | 1 | 2014 | 1001 | 0.270 |
Why?
|
| Calcium Signaling | 2 | 2023 | 254 | 0.270 |
Why?
|
| Tissue Scaffolds | 1 | 2008 | 79 | 0.260 |
Why?
|
| Immunohistochemistry | 3 | 2017 | 1719 | 0.260 |
Why?
|
| Decompression, Surgical | 2 | 2004 | 91 | 0.260 |
Why?
|
| Time Factors | 8 | 2022 | 6435 | 0.260 |
Why?
|
| Depression | 2 | 2022 | 1350 | 0.250 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 2438 | 0.250 |
Why?
|
| Analgesics, Opioid | 2 | 2023 | 470 | 0.250 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2021 | 189 | 0.240 |
Why?
|
| RNA, Messenger | 4 | 2017 | 2676 | 0.240 |
Why?
|
| Eye Movements | 2 | 2017 | 79 | 0.240 |
Why?
|
| Cerebral Cortex | 2 | 2021 | 484 | 0.240 |
Why?
|
| Mice, Transgenic | 5 | 2021 | 2450 | 0.230 |
Why?
|
| Aged, 80 and over | 5 | 2017 | 7113 | 0.230 |
Why?
|
| Ulnar Nerve Compression Syndromes | 1 | 2004 | 2 | 0.230 |
Why?
|
| Ulnar Nerve | 1 | 2004 | 11 | 0.230 |
Why?
|
| Elbow | 1 | 2004 | 8 | 0.230 |
Why?
|
| Germinoma | 1 | 2004 | 32 | 0.220 |
Why?
|
| Nervous System Neoplasms | 1 | 2004 | 9 | 0.220 |
Why?
|
| Thoracic Outlet Syndrome | 1 | 2004 | 19 | 0.220 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2004 | 75 | 0.210 |
Why?
|
| Carpal Tunnel Syndrome | 1 | 2004 | 23 | 0.210 |
Why?
|
| Brain Concussion | 3 | 2016 | 238 | 0.210 |
Why?
|
| Glasgow Coma Scale | 2 | 2014 | 199 | 0.210 |
Why?
|
| Morphine Derivatives | 1 | 2023 | 6 | 0.210 |
Why?
|
| Decompression | 1 | 2023 | 4 | 0.210 |
Why?
|
| Postoperative Complications | 4 | 2023 | 3129 | 0.210 |
Why?
|
| Chondrocytes | 2 | 2017 | 51 | 0.210 |
Why?
|
| G-Quadruplexes | 1 | 2023 | 12 | 0.210 |
Why?
|
| Infrared Rays | 1 | 2023 | 23 | 0.200 |
Why?
|
| Clonidine | 1 | 2023 | 33 | 0.200 |
Why?
|
| Aptamers, Nucleotide | 1 | 2023 | 36 | 0.200 |
Why?
|
| Pyrans | 2 | 2021 | 10 | 0.200 |
Why?
|
| Arousal | 1 | 2023 | 81 | 0.200 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2016 | 253 | 0.200 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2023 | 58 | 0.200 |
Why?
|
| Animals, Newborn | 2 | 2016 | 1034 | 0.190 |
Why?
|
| Intracranial Pressure | 5 | 2017 | 212 | 0.190 |
Why?
|
| Anesthetics, Local | 1 | 2023 | 86 | 0.190 |
Why?
|
| Epinephrine | 1 | 2023 | 155 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2023 | 3852 | 0.190 |
Why?
|
| Hedgehog Proteins | 2 | 2016 | 263 | 0.190 |
Why?
|
| Prognosis | 4 | 2019 | 5004 | 0.190 |
Why?
|
| Intracranial Aneurysm | 2 | 2018 | 91 | 0.190 |
Why?
|
| Brain Edema | 3 | 2018 | 70 | 0.180 |
Why?
|
| Endarterectomy, Carotid | 1 | 2022 | 85 | 0.180 |
Why?
|
| Doxycycline | 1 | 2022 | 121 | 0.180 |
Why?
|
| Hyponatremia | 1 | 2022 | 74 | 0.180 |
Why?
|
| Transplantation, Homologous | 2 | 2014 | 648 | 0.180 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2021 | 15 | 0.170 |
Why?
|
| Treatment Outcome | 10 | 2022 | 12996 | 0.170 |
Why?
|
| Carotid Stenosis | 1 | 2022 | 123 | 0.170 |
Why?
|
| Phosphoproteins | 2 | 2023 | 443 | 0.170 |
Why?
|
| Coccyx | 1 | 2020 | 3 | 0.170 |
Why?
|
| Surgical Wound Infection | 1 | 2023 | 271 | 0.170 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 1828 | 0.170 |
Why?
|
| SMARCB1 Protein | 1 | 2020 | 48 | 0.160 |
Why?
|
| Pain, Postoperative | 1 | 2023 | 273 | 0.160 |
Why?
|
| DNA-Binding Proteins | 2 | 2021 | 1993 | 0.160 |
Why?
|
| Seizures | 2 | 2016 | 895 | 0.160 |
Why?
|
| Sleep | 1 | 2023 | 373 | 0.160 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2019 | 35 | 0.160 |
Why?
|
| Cell Survival | 3 | 2019 | 869 | 0.150 |
Why?
|
| Cancer Pain | 2 | 2017 | 27 | 0.150 |
Why?
|
| Patient Readmission | 1 | 2023 | 424 | 0.150 |
Why?
|
| Collagen Type II | 2 | 2017 | 25 | 0.150 |
Why?
|
| Child, Preschool | 5 | 2017 | 14715 | 0.150 |
Why?
|
| Eye Movement Measurements | 2 | 2017 | 3 | 0.150 |
Why?
|
| Ischemic Postconditioning | 1 | 2018 | 5 | 0.150 |
Why?
|
| Phosphopyruvate Hydratase | 2 | 2016 | 31 | 0.150 |
Why?
|
| Risk Factors | 5 | 2023 | 10893 | 0.150 |
Why?
|
| Cognitive Dysfunction | 1 | 2023 | 313 | 0.150 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2016 | 137 | 0.150 |
Why?
|
| Infant | 3 | 2020 | 13032 | 0.140 |
Why?
|
| Ocimum sanctum | 1 | 2018 | 2 | 0.140 |
Why?
|
| Cell Count | 2 | 2016 | 234 | 0.140 |
Why?
|
| Blotting, Western | 2 | 2018 | 1080 | 0.140 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2023 | 540 | 0.140 |
Why?
|
| Hydrogen Peroxide | 1 | 2019 | 124 | 0.140 |
Why?
|
| Genes, Neoplasm | 1 | 2018 | 88 | 0.140 |
Why?
|
| Length of Stay | 2 | 2014 | 1379 | 0.140 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 402 | 0.140 |
Why?
|
| Chronic Pain | 1 | 2020 | 148 | 0.140 |
Why?
|
| Glucosides | 1 | 2018 | 48 | 0.140 |
Why?
|
| Biomarkers | 3 | 2016 | 3373 | 0.130 |
Why?
|
| Flavonoids | 1 | 2018 | 85 | 0.130 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2017 | 21 | 0.130 |
Why?
|
| Neoplasms | 2 | 2023 | 2953 | 0.130 |
Why?
|
| Thoracic Vertebrae | 1 | 2017 | 68 | 0.130 |
Why?
|
| Quality Improvement | 1 | 2023 | 695 | 0.130 |
Why?
|
| Bumetanide | 1 | 2016 | 7 | 0.130 |
Why?
|
| Nogo Receptor 1 | 2 | 2014 | 9 | 0.130 |
Why?
|
| Cell Membrane Permeability | 1 | 2016 | 72 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 299 | 0.130 |
Why?
|
| User-Computer Interface | 2 | 2008 | 168 | 0.130 |
Why?
|
| Calpain | 1 | 2016 | 43 | 0.130 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2016 | 30 | 0.130 |
Why?
|
| Spinal Neoplasms | 1 | 2017 | 74 | 0.130 |
Why?
|
| Head Protective Devices | 1 | 2016 | 22 | 0.130 |
Why?
|
| Trauma Centers | 1 | 2018 | 197 | 0.130 |
Why?
|
| Pancreatic Stellate Cells | 1 | 2016 | 9 | 0.130 |
Why?
|
| Behavior, Animal | 2 | 2022 | 506 | 0.130 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2019 | 492 | 0.130 |
Why?
|
| Catheters, Indwelling | 1 | 2017 | 157 | 0.130 |
Why?
|
| Ammonia | 1 | 2016 | 77 | 0.130 |
Why?
|
| Cerebrovascular Circulation | 2 | 2017 | 476 | 0.120 |
Why?
|
| Depressive Disorder, Major | 1 | 2022 | 461 | 0.120 |
Why?
|
| Visual Perception | 1 | 2017 | 136 | 0.120 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2017 | 111 | 0.120 |
Why?
|
| Substance P | 1 | 2016 | 37 | 0.120 |
Why?
|
| Tubulin | 1 | 2016 | 73 | 0.120 |
Why?
|
| Thrombocytopenia | 1 | 2018 | 233 | 0.120 |
Why?
|
| Melatonin | 1 | 2016 | 30 | 0.120 |
Why?
|
| Facial Nerve | 1 | 2016 | 26 | 0.120 |
Why?
|
| Evoked Potentials | 1 | 2016 | 121 | 0.120 |
Why?
|
| Nerve Growth Factors | 1 | 2016 | 73 | 0.120 |
Why?
|
| TRPV Cation Channels | 1 | 2016 | 46 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2023 | 916 | 0.120 |
Why?
|
| Survival Rate | 2 | 2018 | 2183 | 0.120 |
Why?
|
| Neuroma, Acoustic | 1 | 2016 | 33 | 0.120 |
Why?
|
| Protease Inhibitors | 1 | 2016 | 97 | 0.120 |
Why?
|
| Radiosurgery | 1 | 2017 | 147 | 0.120 |
Why?
|
| Preoperative Care | 2 | 2016 | 368 | 0.120 |
Why?
|
| Intracranial Hypertension | 1 | 2017 | 133 | 0.120 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2016 | 86 | 0.120 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2016 | 171 | 0.120 |
Why?
|
| Electrophysiology | 1 | 2016 | 268 | 0.120 |
Why?
|
| Blood Platelets | 1 | 2018 | 323 | 0.120 |
Why?
|
| Endothelial Cells | 1 | 2019 | 527 | 0.120 |
Why?
|
| Ischemia | 1 | 2018 | 371 | 0.120 |
Why?
|
| Microglia | 1 | 2016 | 138 | 0.110 |
Why?
|
| Exosomes | 1 | 2015 | 57 | 0.110 |
Why?
|
| Pyrroles | 1 | 2016 | 182 | 0.110 |
Why?
|
| Sex Factors | 2 | 2016 | 1348 | 0.110 |
Why?
|
| Oculomotor Nerve Diseases | 1 | 2014 | 18 | 0.110 |
Why?
|
| Abducens Nerve Diseases | 1 | 2014 | 11 | 0.110 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 1966 | 0.110 |
Why?
|
| Ocular Motility Disorders | 1 | 2015 | 38 | 0.110 |
Why?
|
| Frontotemporal Dementia | 1 | 2015 | 73 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2022 | 1062 | 0.110 |
Why?
|
| S100 Calcium Binding Protein A6 | 1 | 2014 | 4 | 0.110 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 604 | 0.110 |
Why?
|
| Glycoproteins | 1 | 2016 | 377 | 0.110 |
Why?
|
| Single-Blind Method | 1 | 2014 | 242 | 0.110 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 701 | 0.110 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2014 | 59 | 0.110 |
Why?
|
| Critical Care Nursing | 1 | 2014 | 6 | 0.110 |
Why?
|
| Child | 6 | 2017 | 25756 | 0.110 |
Why?
|
| S100 Calcium Binding Protein beta Subunit | 1 | 2014 | 17 | 0.110 |
Why?
|
| Horses | 1 | 2014 | 104 | 0.110 |
Why?
|
| Analysis of Variance | 1 | 2016 | 1007 | 0.110 |
Why?
|
| Photolysis | 1 | 2013 | 12 | 0.110 |
Why?
|
| Medulla Oblongata | 1 | 2013 | 23 | 0.110 |
Why?
|
| Physical Exertion | 1 | 2014 | 73 | 0.110 |
Why?
|
| Trauma Severity Indices | 1 | 2014 | 89 | 0.110 |
Why?
|
| Stroke | 1 | 2022 | 1081 | 0.100 |
Why?
|
| Pyrazoles | 1 | 2016 | 330 | 0.100 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2013 | 21 | 0.100 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 486 | 0.100 |
Why?
|
| Infant, Newborn | 2 | 2017 | 8535 | 0.100 |
Why?
|
| Neuroblastoma | 1 | 2019 | 550 | 0.100 |
Why?
|
| Brain Stem Neoplasms | 1 | 2013 | 47 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 1552 | 0.100 |
Why?
|
| Injury Severity Score | 1 | 2014 | 228 | 0.100 |
Why?
|
| Rats, Wistar | 1 | 2014 | 329 | 0.100 |
Why?
|
| Athletes | 1 | 2014 | 73 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 1284 | 0.100 |
Why?
|
| Explosions | 1 | 2012 | 8 | 0.100 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2013 | 165 | 0.100 |
Why?
|
| Glutamic Acid | 1 | 2013 | 209 | 0.100 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 5394 | 0.100 |
Why?
|
| Hypothermia, Induced | 1 | 2013 | 170 | 0.100 |
Why?
|
| Hematoma, Subdural, Chronic | 1 | 2012 | 13 | 0.090 |
Why?
|
| Immunogenetic Phenomena | 1 | 2012 | 1 | 0.090 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2012 | 106 | 0.090 |
Why?
|
| Sciatic Nerve | 1 | 2012 | 62 | 0.090 |
Why?
|
| Neuroimaging | 1 | 2015 | 375 | 0.090 |
Why?
|
| Age Factors | 2 | 2016 | 2920 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 2303 | 0.090 |
Why?
|
| Brachial Plexus Neuritis | 1 | 2011 | 5 | 0.090 |
Why?
|
| Progesterone | 1 | 2013 | 450 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 613 | 0.090 |
Why?
|
| Cells, Cultured | 4 | 2019 | 3044 | 0.090 |
Why?
|
| Mice, Knockout | 3 | 2014 | 3866 | 0.090 |
Why?
|
| Anticonvulsants | 1 | 2013 | 390 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 2061 | 0.080 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 541 | 0.080 |
Why?
|
| Cerebral Ventricles | 1 | 2011 | 83 | 0.080 |
Why?
|
| Cell Line, Tumor | 4 | 2021 | 3688 | 0.080 |
Why?
|
| Hypoxia | 1 | 2012 | 259 | 0.080 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2011 | 150 | 0.080 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 989 | 0.080 |
Why?
|
| Intracranial Hemorrhages | 1 | 2011 | 81 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2016 | 825 | 0.080 |
Why?
|
| Intensive Care Units | 1 | 2014 | 524 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 727 | 0.080 |
Why?
|
| Brachial Plexus Neuropathies | 1 | 2009 | 9 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2014 | 1226 | 0.080 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 563 | 0.080 |
Why?
|
| Pyridines | 1 | 2011 | 249 | 0.080 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2009 | 62 | 0.080 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 3082 | 0.080 |
Why?
|
| Guided Tissue Regeneration | 1 | 2008 | 3 | 0.080 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2011 | 337 | 0.070 |
Why?
|
| Cartilage, Articular | 1 | 2009 | 64 | 0.070 |
Why?
|
| Databases, Factual | 1 | 2013 | 1228 | 0.070 |
Why?
|
| Monitoring, Physiologic | 1 | 2011 | 380 | 0.070 |
Why?
|
| Myelin Sheath | 1 | 2009 | 125 | 0.070 |
Why?
|
| Hemangioma | 1 | 2009 | 97 | 0.070 |
Why?
|
| Lung Diseases | 1 | 2012 | 408 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 2674 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 1381 | 0.070 |
Why?
|
| Incidence | 1 | 2016 | 3362 | 0.070 |
Why?
|
| Factor VIIa | 1 | 2008 | 24 | 0.070 |
Why?
|
| Wound Healing | 1 | 2012 | 476 | 0.070 |
Why?
|
| beta Catenin | 1 | 2009 | 227 | 0.070 |
Why?
|
| Osteoarthritis | 1 | 2009 | 103 | 0.070 |
Why?
|
| Hemostatics | 1 | 2008 | 60 | 0.070 |
Why?
|
| Stress, Mechanical | 1 | 2008 | 173 | 0.070 |
Why?
|
| Texas | 1 | 2016 | 3632 | 0.070 |
Why?
|
| Dementia | 1 | 2012 | 475 | 0.070 |
Why?
|
| Smoking | 1 | 2012 | 940 | 0.070 |
Why?
|
| Positive-Pressure Respiration | 1 | 2007 | 85 | 0.060 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 287 | 0.060 |
Why?
|
| Neuroprotective Agents | 1 | 2008 | 161 | 0.060 |
Why?
|
| Electromyography | 2 | 2021 | 140 | 0.060 |
Why?
|
| Interleukin-1beta | 2 | 2016 | 163 | 0.060 |
Why?
|
| Microsurgery | 1 | 2005 | 62 | 0.060 |
Why?
|
| Autophagy | 2 | 2021 | 426 | 0.060 |
Why?
|
| Neurofibroma | 1 | 2004 | 7 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 1350 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2014 | 1252 | 0.050 |
Why?
|
| Mutation | 3 | 2023 | 6245 | 0.050 |
Why?
|
| Respiration, Artificial | 1 | 2007 | 501 | 0.050 |
Why?
|
| Intracranial Hypotension | 1 | 2003 | 12 | 0.050 |
Why?
|
| Spinal Puncture | 1 | 2003 | 52 | 0.050 |
Why?
|
| Nervous System Diseases | 1 | 2007 | 411 | 0.050 |
Why?
|
| Skull Base | 1 | 2003 | 51 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2023 | 160 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2019 | 1668 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 2022 | 137 | 0.040 |
Why?
|
| Functional Laterality | 2 | 2013 | 195 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2023 | 383 | 0.040 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2020 | 32 | 0.040 |
Why?
|
| Apoptosis | 2 | 2018 | 1900 | 0.040 |
Why?
|
| Patient Selection | 1 | 2004 | 730 | 0.040 |
Why?
|
| Low Back Pain | 1 | 2020 | 40 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2017 | 2163 | 0.040 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 174 | 0.040 |
Why?
|
| Tight Junctions | 1 | 2019 | 40 | 0.040 |
Why?
|
| Antigens, CD34 | 1 | 2019 | 109 | 0.040 |
Why?
|
| Malondialdehyde | 1 | 2018 | 52 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2019 | 111 | 0.040 |
Why?
|
| Permeability | 1 | 2019 | 122 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2018 | 124 | 0.040 |
Why?
|
| Peroxidase | 1 | 2018 | 64 | 0.040 |
Why?
|
| Phytochemicals | 1 | 2018 | 9 | 0.040 |
Why?
|
| Thrombopoiesis | 1 | 2018 | 12 | 0.040 |
Why?
|
| Alanine Transaminase | 1 | 2018 | 162 | 0.040 |
Why?
|
| Metabolomics | 1 | 2022 | 473 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2018 | 176 | 0.030 |
Why?
|
| Reperfusion Injury | 1 | 2018 | 110 | 0.030 |
Why?
|
| Algorithms | 2 | 2014 | 1720 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2019 | 257 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2019 | 1046 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 309 | 0.030 |
Why?
|
| Narcotics | 1 | 2017 | 61 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 688 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2018 | 343 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 826 | 0.030 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2017 | 99 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2018 | 258 | 0.030 |
Why?
|
| Spine | 1 | 2017 | 147 | 0.030 |
Why?
|
| Capsaicin | 1 | 2016 | 20 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 955 | 0.030 |
Why?
|
| Pedigree | 1 | 2020 | 1724 | 0.030 |
Why?
|
| Nerve Growth Factor | 1 | 2016 | 25 | 0.030 |
Why?
|
| Binding Sites | 1 | 2019 | 1255 | 0.030 |
Why?
|
| Stents | 1 | 2022 | 874 | 0.030 |
Why?
|
| Swine | 2 | 2011 | 1195 | 0.030 |
Why?
|
| Prions | 1 | 2015 | 16 | 0.030 |
Why?
|
| Nanotubes | 1 | 2015 | 18 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2016 | 238 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2016 | 99 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2016 | 295 | 0.030 |
Why?
|
| United States | 3 | 2018 | 11619 | 0.030 |
Why?
|
| Motion Pictures | 1 | 2014 | 6 | 0.030 |
Why?
|
| Pancreas | 1 | 2016 | 222 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 397 | 0.030 |
Why?
|
| Automation | 1 | 2014 | 63 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2015 | 77 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2018 | 439 | 0.030 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2014 | 29 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 689 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 755 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 329 | 0.030 |
Why?
|
| Certification | 1 | 2014 | 72 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2014 | 304 | 0.030 |
Why?
|
| SNARE Proteins | 1 | 2013 | 21 | 0.030 |
Why?
|
| Anisotropy | 1 | 2013 | 126 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2014 | 235 | 0.030 |
Why?
|
| Schools, Medical | 1 | 2014 | 122 | 0.030 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 84 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2013 | 157 | 0.030 |
Why?
|
| Sports | 1 | 2014 | 66 | 0.030 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2013 | 117 | 0.030 |
Why?
|
| Neural Inhibition | 1 | 2013 | 110 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2014 | 328 | 0.020 |
Why?
|
| Radiography | 1 | 2015 | 818 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2022 | 3710 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 598 | 0.020 |
Why?
|
| Atrophy | 1 | 2012 | 251 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 679 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2013 | 303 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 2850 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2011 | 57 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 4538 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2018 | 1963 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2011 | 115 | 0.020 |
Why?
|
| Neuropeptides | 1 | 2011 | 117 | 0.020 |
Why?
|
| Oximetry | 1 | 2011 | 178 | 0.020 |
Why?
|
| Students, Medical | 1 | 2014 | 362 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2011 | 195 | 0.020 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2009 | 52 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 1493 | 0.020 |
Why?
|
| Memory | 1 | 2012 | 355 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2011 | 258 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2009 | 61 | 0.020 |
Why?
|
| Learning | 1 | 2012 | 370 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 1563 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 3358 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 1835 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2009 | 314 | 0.020 |
Why?
|
| Embolization, Therapeutic | 1 | 2009 | 223 | 0.020 |
Why?
|
| Homeostasis | 1 | 2011 | 722 | 0.020 |
Why?
|
| Respiration | 1 | 2007 | 124 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2011 | 908 | 0.020 |
Why?
|
| Biopsy | 1 | 2009 | 1288 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2012 | 3415 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2014 | 6526 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2016 | 4717 | 0.010 |
Why?
|
| Blood Patch, Epidural | 1 | 2003 | 6 | 0.010 |
Why?
|